Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
about
Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutationsRifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV regionMatching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California.Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994New approaches in the diagnosis and treatment of latent tuberculosis infectionTiming of antiretroviral therapy for HIV in the setting of TB treatment.Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru.Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampinLow Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in ZambiaPotential for adaptation overrides cost of resistance.Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia.Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.Quantifying the impact of drug combination regimens on TB treatment efficacy and multidrug resistance probability.Risk factors for rifampin mono-resistant tuberculosis.Risk factors for rifampin-monoresistant tuberculosis: A case-control study.
P2860
Q28379306-50E6F256-BF11-487A-80EB-7F028FA0B9B9Q28534875-6151C6E5-D108-4025-BC02-18A4AEF9C898Q30843408-0D5CAB3D-5C42-4480-8B99-AC241676F726Q33964071-673442DD-D1F6-4621-9BA6-3EA3E953F1BDQ34199618-E4D7EEE6-1BE8-4ECA-9606-297AC8E10AF9Q34419185-FC9B4166-9438-497E-91C4-37C69CE607ECQ34475542-25454639-D57A-467D-B1B3-36F709A75063Q34554997-89D5F546-92DF-46F2-9B41-D6CEEECAD12AQ35138391-DBFCFF57-9459-4083-BC31-BF87CA20AE87Q35910170-782091B9-40B1-4E42-A8DB-2619D67BA881Q38966881-AECB4608-447B-4CE2-A81F-5510FCCB1748Q40065997-B5485B71-56E3-4E19-80A5-786848141F45Q43659124-5976AE32-DD3C-418E-89F1-499F68E1AD17Q46529547-65B12937-E9EA-49CE-949E-D36D1B0FB14DQ50862469-4A2EAFB5-D460-41D8-B914-826511D1EDD4Q50883380-74DE97E8-2851-405D-947B-578863618DFAQ54106641-FEB3777F-69FC-4D9A-A546-E3651DE67541
P2860
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@en
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@nl
type
label
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@en
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@nl
prefLabel
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@en
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@nl
P2093
P1476
Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
@en
P2093
Eisenach KD
Goldberg SV
Thompson RL
Williams DL
P304
P356
10.1164/AJRCCM.152.3.7663785
P407
P577
1995-09-01T00:00:00Z